Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
15,480
NCT00135226
ASCEND: A Study of Cardiovascular Events iN Diabetes
Phase: Phase 4
Role: Collaborator
Start: Mar 31, 2005
Completion: Jul 31, 2037